GAP INNOVATIONS
Live / Applied — First extension granted (statement of use) (as of 27 Feb 2026)
What this means for you
Not registered yet, but its 04 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98116918
- Mark type
- Stylized text
- Filed
- 04 Aug 2023
- Published for opposition
- 18 Mar 2025
- Attorney of record
- Christopher A. Proskey
Goods and services
- Class 042 — Scientific and technological services: Scientific research in the nature of conducting clinical trials and research for others in the field of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Medical and scientific research, namely, conducting clinical trials for others; Medical and scientific research, namely, conducting clinical trials for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
- Class 044 — Medical, beauty and agricultural services: Healthcare services, namely, administering care to patients; Healthcare services, namely, administering care to patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, administering tests for patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Healthcare services, namely, taking samples from patients with Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Establishing a blood bank of biological samples related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services in the field of Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases; Providing health screening services related to Alzheimer's, neurodegenerative diseases and other neurological and central nervous system diseases
Owner
- Global Alzheimer's Platform Foundation Inc., Washington, DC, US
- Global Alzheimer's Platform Foundation Inc., Washington, DC, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2026 — SOU EXTENSION 1 GRANTED
- 27 Feb 2026 — SOU EXTENSION 1 FILED
- 27 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jul 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 02 Apr 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Nov 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 07 Nov 2024 — FINAL REFUSAL E-MAILED
- 07 Nov 2024 — FINAL REFUSAL WRITTEN
- 08 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED